ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Diabetes: Molecular Mechanisms
This article is part of the Research TopicHerbal Medicine for the Treatment of Chronic Metabolic Diseases, Volume IIView all 44 articles
Inulin and Lycium barbarum polysaccharides mitigate the diabetic inflammatory response by modulating bile acid metabolism to enhance regulatory T cell (Treg) activation in a rat model of diabetes
Provisionally accepted- 1Ningxia medical university, Yinchuan, China
- 2People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that poses a serious threat to human health. Currently, there are still no completely effective treatment options. Modulating the intestinal flora and its metabolites may represent a promising new approach for diabetes therapy. Regulating the intestinal microbiota and its metabolites through prebiotics, mediated by regulatory T (Treg) cells. Objective: The purpose of this study was to investigate the improvement of diabetes-related chronic inflammation by examining the effects of inulin (INU) and Lycium barbarum polysaccharides (LBP) in diabetic rats. This was achieved by modulating the bile acids-metabolites of the intestinal flora through the FXR-FGF15-FGFR4 axis, thereby activating Treg cells in vivo and alleviating the inflammatory state associated with diabetes. Methods: A diabetic rat model was established by a high-fat diet and streptozotocin (STZ) injections. Sprague-Dawley rats were randomly allocated into four groups: type 2 diabetes mellitus (T2DM), T2DM with INU group (T2DM+INU), T2DM with LBP group (T2DM+LBP), and T2DM with INU and LBP group (T2DM+INU+LBP). Results: INU and LBP treatments significantly decreased the levels of inflammatory cytokines, including MCP-1, IL-18, NF-κB, NLRP3, superoxide dismutase (SOD), and malondialdehyde (MDA). Moreover, these alleviations of the inflammatory state of diabetes were partially attributed to an increased proportion of Treg cells. We found the abundance of Tauro β-muricholic acid (TβMCA) was reduced following INU and LBP treatment, while the relative abundances of chenodeoxycholic acid (CDCA), lithocholic acid (LCA), and hyocholic acid (HCA) were all increased compared to the untreated group. Mechanically, INU and LBP significantly influenced the negative feedback regulation of the FXR-FGF15-FGFR4 axis via intestinal bile acids, thereby increasing the proportion of Treg cells in the periphery of diabetic rats. Intriguingly, an increase of Treg cells after INU and LBP intervention was notably correlated with the improvement of the inflammatory state of diabetes. Conclusions: INU and LBP modulate bile acids derived from the intestinal flora to improve the chronic inflammatory status of diabetic rats, specifically, both of which exert their effectiveness by regulating gut microbial bile acids metabolites through the FXR-FGF15-FGFR4 axis to activate Treg cells.
Keywords: Bile acids, FXR-FGF15-FGFR4 axis, Inulin, Lycium barbarum polysaccharides, Treg cells, type 2 diabetes mellitus
Received: 15 Sep 2025; Accepted: 28 Nov 2025.
Copyright: © 2025 Lu, Luo, Li, Yang, Cao, Yanfang, Ma, Zhao, Zheng and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hai Xia Lu
Qian Zhao
Yali Zheng
Hao Wang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
